<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-87083" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Posttraumatic Headache</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tessler</surname>
            <given-names>Joseph</given-names>
          </name>
          <aff>Division of Physical Medicine and Rehabilitation, Department of Orthopaedics &#x00026; Rehabilitation, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Horn</surname>
            <given-names>Lawrence J.</given-names>
          </name>
          <aff>University of New Mexico</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joseph Tessler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lawrence Horn declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>9</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-87083.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Post-traumatic headaches (PTHA) are a common sequela of traumatic brain injury (TBI) and may progress to chronic and possibly debilitating conditions. This activity reviews the evaluation, management, and treatment of post-traumatic headaches. It highlights the role of the healthcare team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the various etiologies of post-traumatic headaches.</p></list-item><list-item><p>Assess&#x000a0;the common patient presentations of a patient with post-traumatic headache.</p></list-item><list-item><p>Evaluate&#x000a0;the management considerations for patients with post-traumatic headache.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among the interprofessional team to enhance care delivery for patients affected by post-traumatic headaches.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=87083&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=87083">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-87083.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Post-traumatic headaches (PTHA) are a common sequela of traumatic brain injury (TBI) and may progress to chronic and possibly debilitating conditions.<xref ref-type="bibr" rid="article-87083.r1">[1]</xref> PTHA can be further subdivided into 2 general categories. Acute PTHA is attributed to TBI that resolves within 3 months, and persistent PTHA has not resolved within&#x000a0;3 months.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref>&#x000a0;There are several potentially overlapping phenotypes of PTHA.</p>
      </sec>
      <sec id="article-87083.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>According to the latest International Classification of Headache Disorders (ICHD-3),&#x000a0;PTHAs are defined as a secondary headache with onset within&#x000a0;7 days following trauma or injury, within&#x000a0;7 days after recovering consciousness, or within&#x000a0;7 days after recovering the ability to sense and report pain.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref>&#x000a0;However, this definition has been challenged recently, as some patients may report several months to&#x000a0;1 year after trauma or injury.<xref ref-type="bibr" rid="article-87083.r3">[3]</xref>&#x000a0;The temporal definitions provided by the ICHD-3 lack specific phenotypic diagnoses that would enable practitioners to treat and manage the various forms of PTHA.</p>
        <p>
<bold>Military</bold>
</p>
        <p>PTHA is a significant cause of debility in military personnel. Due to the immense physical and psychological toll compared to civilian trauma/injury, combat TBI and the subsequent sequelae warrant separate mention. There is a considerable increase in the overlap between PTHA and post-traumatic stress disorder (PTSD). Combat-related explosions are the most common causes of U.S. military personnel injury.<xref ref-type="bibr" rid="article-87083.r3">[3]</xref></p>
      </sec>
      <sec id="article-87083.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Headache is the most common physical complaint following TBI, with a prevalence ranging from 30% to 90%. Of those patients, 18% to 22% reported PTHAs after 1 year. The wide range of prevalence may be because the majority of TBI cases are defined as mild TBI (mTBI), ie, concussions, in which patients may not seek immediate medical attention. PTHA&#x000a0;appears to be more frequent in patients recovering from mTBI than in those who experienced moderate to severe TBI.<xref ref-type="bibr" rid="article-87083.r3">[3]</xref>&#x000a0;However, patients with moderate to severe TBI may be more likely to report persistent chronic PTHA. PTHA is more frequent in females than males, with a ratio of 2&#x000a0;to 1. Evans et al reported that 45% of patients with a past medical history of headaches are more likely to report PTHA.&#x000a0;Of the several subtypes of headaches classified by the ICHD, migraine-like and tension-type headaches were the most commonly reported.<xref ref-type="bibr" rid="article-87083.r4">[4]</xref>&#x000a0;An Australian study found that m TBI patients were&#x000a0;7 times more likely to report headaches after trauma than non-TBI trauma patients.<xref ref-type="bibr" rid="article-87083.r5">[5]</xref></p>
      </sec>
      <sec id="article-87083.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;PTHA&#x000a0;is still unknown; however, several theories have been proposed to explain its underlying cause. These include impaired descending modulation, neurometabolic changes, and activation of the trigeminal sensory system.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref>&#x000a0;PTHA likely involves overlapping, multifaceted processes.</p>
        <p>
<bold>Impaired Descending Modulation</bold>
</p>
        <p>This theory&#x000a0;derives from the similarity between migraine and PTHA. A study by Schwedt et al showed structural differences in cortical thickness and cerebral volumes in PTHA patients and healthy controls.<xref ref-type="bibr" rid="article-87083.r6">[6]</xref>&#x000a0;TBI may result in diffuse axonal injury that may result in structural remodeling of cortical and subcortical regions in the somatosensory and the insular cortex, leading to impaired neuromodulation of descending pain-modulating pathways.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref>&#x000a0;</p>
        <p>
<bold>Neurometabolic Changes</bold>
</p>
        <p>Research suggests that TBI produces changes in brain metabolic activity. Physical trauma leads to cellular injury, resulting in an unregulated ion-exchange neurotransmitter release. The increased neuronal activity results in metabolic stress (lactate and free radicals), leading to axonal damage (secondary axotomy).<xref ref-type="bibr" rid="article-87083.r2">[2]</xref> Cortical spreading depression (CSD) is an electrophysiological process that occurs during migraine auras.<xref ref-type="bibr" rid="article-87083.r7">[7]</xref> Recent studies have shown CSD contributes to secondary injury after TBI and, therefore, may play a role in PTHA.<xref ref-type="bibr" rid="article-87083.r8">[8]</xref>&#x000a0;Cellular depolarization in CSD causes excessive glutamate and potassium release, increasing neuronal excitability and activation of the trigeminal sensory system. Studies have shown that TBI patients release adenosine triphosphate (ATP), similar to CSD.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref></p>
        <p>
<bold>Trigeminal Sensory System Activation</bold>
</p>
        <p>The trigeminal sensory system may also be affected by neuroinflammation&#x02014;inflammatory processes in the brain increase after TBI. Neuroinflammation may also increase the central nervous system (CNS) excitability, resulting in CSD and subsequent activation of the trigeminal sensory system.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref> The trigeminal system can also&#x000a0;undergo stimulation by nociceptive signals from upper cervical afferents due to overlap in their respective signaling tracts.<xref ref-type="bibr" rid="article-87083.r9">[9]</xref><xref ref-type="bibr" rid="article-87083.r10">[10]</xref> The convergence between cervical afferents and trigeminal nerve pathways supports the observation that treatments for cervical neck pain generators can help alleviate PTHA.</p>
        <p>
<bold>Other Theories</bold>
</p>
        <p>Additional possible contributions in PTHA include hyperadrenergic activity, activation of extracranial dural afferents, and meningeal irritation due to craniotomy.<xref ref-type="bibr" rid="article-87083.r1">[1]</xref><xref ref-type="bibr" rid="article-87083.r2">[2]</xref>&#x000a0;Glymphatic pathway dysfunction also&#x000a0;carries implications in PTHA.<xref ref-type="bibr" rid="article-87083.r11">[11]</xref></p>
      </sec>
      <sec id="article-87083.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients should be evaluated and questioned about headaches after TBI, whether mild or moderate/severe. Per ICHD-3,&#x000a0;PTHA should occur within 7 days of acute insult. Patients with PTHA lasting more than 3 months are considered to have persistent PTHA. PTHA does not have a specific phenotype, and TBI patients report symptoms similar to different primary and secondary headaches.<xref ref-type="bibr" rid="article-87083.r1">[1]</xref>&#x000a0;Military personnel with a history of combat involvement may report additional symptoms. PTHA is included in the constellation of symptoms known as post-concussive syndrome (PCS), which includes dizziness, fatigue, irritability, anxiety, insomnia, and decreased cognition.<xref ref-type="bibr" rid="article-87083.r3">[3]</xref>&#x000a0;PTHA and PCS may be further obfuscated in this population by the greater prevalence of PTSD than in the civilian population. Patients should be questioned about headache severity and associated symptoms during the patient encounter. The physical examination should include assessing the cervical range of motion, musculoskeletal palpation of the head and cervical neck, and neurologic status.</p>
      </sec>
      <sec id="article-87083.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>PTHA, like other primary headaches, is a clinical diagnosis. Routine diagnostic imaging and laboratory tests are unnecessary and offer little clinical value.<xref ref-type="bibr" rid="article-87083.r12">[12]</xref>&#x000a0;Patients with PTHA after TBI show no structural abnormalities on brain imaging.<xref ref-type="bibr" rid="article-87083.r13">[13]</xref>&#x000a0;Patients with a diagnosis of PTHA after TBI do not require additional imaging if they have had an appropriate workup for TBI. Patients with a history of TBI and new complaints of headaches require additional imaging to rule out other causes of headaches besides PTHA. Computed tomography (CT) of the head without contrast should be completed to rule out acute cerebral hemorrhage, especially in the elderly. Cerebral magnetic resonance imaging (MRI) should be ordered to rule out ischemic infarction and masses. Also, any acute change in neurologic status or sudden change in frequency and intensity of headache may warrant additional imaging to rule out other causes.<xref ref-type="bibr" rid="article-87083.r14">[14]</xref><xref ref-type="bibr" rid="article-87083.r15">[15]</xref></p>
      </sec>
      <sec id="article-87083.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management and treatment for&#x000a0;PTHA involve a multifaceted approach that may include oral medications, musculoskeletal manipulation and treatment, interventional procedures, and behavioral therapy. A review of non-pharmacologic therapy modalities and biopsychosocial factors concluded that a multi-disciplinary approach was most effective in PTHA management. The modalities reviewed included cognitive-behavioral therapy (CBT), biofeedback, progressive muscle relaxation therapy, acupuncture, and physical therapy.<xref ref-type="bibr" rid="article-87083.r16">[16]</xref></p>
        <p>The pharmacologic management should be tailored to the specific PTHA phenotype if known.&#x000a0;Several studies have investigated the role of oral and IV medication for acute and preventative treatments.&#x000a0;Acute treatment modalities included oral and intravenous (IV) non-steroidal anti-inflammatories (NSAIDs), triptans, and IV antiemetic medication. Preventative regimens included tricyclic antidepressants (TCAs), anticonvulsants, and gabapentin. Among TCAs, amitriptyline showed benefits in most patients; however, Cushman et al showed that patients receiving gabapentin or amitriptyline showed similar improvements compared to the non-treatment group.<xref ref-type="bibr" rid="article-87083.r17">[17]</xref></p>
        <p>Several interventional procedures have been trialed for PTHA; however, the research lacks controlled trials. A retrospective review of 717 patients showed reduced headache severity and frequency at 6 months.<xref ref-type="bibr" rid="article-87083.r18">[18]</xref> Sporadic case reports have reported benefits with ultrasound-guided nerve blocks to the greater occipital nerve (GON), supraorbital nerve (SON), and lesser occipital nerve (LON).<xref ref-type="bibr" rid="article-87083.r19">[19]</xref>&#x000a0;Below is a summary of preferred methods to treat PTHA based on its primary headache subtype.</p>
        <p>
<bold>Tension-type (TTHA)</bold>
</p>
        <p>The preferred treatment for acute episodic tension-like PTHA is NSAIDs.<xref ref-type="bibr" rid="article-87083.r20">[20]</xref>&#x000a0;Trials have shown the efficacy of the non-selective COX-2 inhibitor lumiracoxib in treating acute episodic tension-type headaches (ETTHA).<xref ref-type="bibr" rid="article-87083.r21">[21]</xref>&#x000a0;TCAs (most notably amitriptyline and nortriptyline) have been the first-line modality of choice in the prophylactic treatment of chronic tension-type headaches (CTTHA).<xref ref-type="bibr" rid="article-87083.r22">[22]</xref>&#x000a0;Mirtazapine has also shown promising results in reducing the frequency of TTH.<xref ref-type="bibr" rid="article-87083.r23">[23]</xref>&#x000a0;Butalbital-containing medications have shown benefit in refractory TTHA.<xref ref-type="bibr" rid="article-87083.r24">[24]</xref>&#x000a0;Triptan medications are ineffective in TTHA management.<xref ref-type="bibr" rid="article-87083.r25">[25]</xref>&#x000a0;Craniomandibular headaches are considered a subtype of tension-type headaches. Intraoral devices can manage headaches related to craniomandibular dysfunction.<xref ref-type="bibr" rid="article-87083.r26">[26]</xref> Patients with headache refractory to intraoral device implants may benefit from botulinum toxin injection into the temporomandibular joint.<xref ref-type="bibr" rid="article-87083.r27">[27]</xref></p>
        <p>
<bold>Migraine-type</bold>
</p>
        <p>Herbal and vitamin supplements have shown&#x000a0;some benefits in managing migraine headaches. There is evidence that magnesium, feverfew, vitamin B2, CoQ10, and <italic toggle="yes">Petasites</italic> can help prevent migraine headaches.<xref ref-type="bibr" rid="article-87083.r28">[28]</xref>&#x000a0;Triptans are the mainstay treatment of acute migraines.<xref ref-type="bibr" rid="article-87083.r29">[29]</xref>&#x000a0;Other abortive treatments for migraine include acetaminophen, NSAIDs, butalbital-containing medications, ergot derivatives, and antiemetics.<xref ref-type="bibr" rid="article-87083.r30">[30]</xref>&#x000a0;Opioids are not recommended for acute migraine therapy.<xref ref-type="bibr" rid="article-87083.r31">[31]</xref>&#x000a0;Monoclonal antibodies to calcitonin gene-related peptides (CGRP-mAbs) were developed to prevent migraine headaches. Other prophylactic therapies include TCAs, the anticonvulsants topiramate and valproate, and beta-blockers.<xref ref-type="bibr" rid="article-87083.r32">[32]</xref>&#x000a0;Botulinum toxin injection is another treatment modality for the management of chronic migraines.<xref ref-type="bibr" rid="article-87083.r33">[33]</xref></p>
        <p>
<bold>Neuralgias and Neuromas</bold>
</p>
        <p>Patients with neuralgias (occipital and cervical) typically do not respond to oral medication or botulinum toxin injections.<xref ref-type="bibr" rid="article-87083.r34">[34]</xref><xref ref-type="bibr" rid="article-87083.r35">[35]</xref> Steroid injections and radiofrequency ablations targeting the GON, SON, and LON have been efficacious.<xref ref-type="bibr" rid="article-87083.r36">[36]</xref> Neuromas can be treated conservatively or surgically. Conservative treatments include opioids, antidepressants, and antispasmodics; however, gabapentin and pregabalin are the drugs of choice for initial treatment. Alternative interventions include transcutaneous magnetic stimulation, ethanol or steroid injections, and radiofrequency ablation. Surgical management includes neuroma resection with or without nerve stimulator implantation.<xref ref-type="bibr" rid="article-87083.r37">[37]</xref></p>
        <p>
<bold>Cervicogenic-type (CHA)</bold>
</p>
        <p>Cervicogenic-type PTHA is typically refractory to oral pharmacological treatment like the neuralgia and neuroma phenotype.<xref ref-type="bibr" rid="article-87083.r34">[34]</xref>&#x000a0;Physiotherapy and manual manipulation of the cervical spine have demonstrated benefits.<xref ref-type="bibr" rid="article-87083.r38">[38]</xref><xref ref-type="bibr" rid="article-87083.r39">[39]</xref> Interventional procedures that have shown promising results in CHA management include occipital nerve blocks (GON and LON) and continuous radiofrequency ablation to the C2 and C3 dorsal root ganglions.<xref ref-type="bibr" rid="article-87083.r36">[36]</xref><xref ref-type="bibr" rid="article-87083.r40">[40]</xref> Linde M et al reported that botulinum toxin injections were not effective in treating cervicogenic headaches.<xref ref-type="bibr" rid="article-87083.r35">[35]</xref></p>
      </sec>
      <sec id="article-87083.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for&#x000a0;PTHA can be&#x000a0;categorized into non-emergent and emergent conditions.</p>
        <p>
<bold>Non-emergent Differential Diagnoses</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Tension headache</p>
          </list-item>
          <list-item>
            <p>Migraine headache</p>
          </list-item>
          <list-item>
            <p>Neuralgias/neuromas</p>
          </list-item>
          <list-item>
            <p>Cervicogenic headache</p>
          </list-item>
          <list-item>
            <p>Medication overuse</p>
          </list-item>
          <list-item>
            <p>Craniomandibular headache</p>
          </list-item>
        </list>
        <p><bold>Emergent Differential Diagnose</bold>s</p>
        <list list-type="order">
          <list-item>
            <p>Ischemic/hemorrhagic stroke</p>
          </list-item>
          <list-item>
            <p>Aneurysm</p>
          </list-item>
          <list-item>
            <p>Cervical artery dissection</p>
          </list-item>
          <list-item>
            <p>Hydrocephalus</p>
          </list-item>
          <list-item>
            <p>Cerebral neoplasm</p>
          </list-item>
          <list-item>
            <p>Temporal arteritis<xref ref-type="bibr" rid="article-87083.r1">[1]</xref><xref ref-type="bibr" rid="article-87083.r41">[41]</xref><xref ref-type="bibr" rid="article-87083.r42">[42]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-87083.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In a study by Hoffman et al, 71% of patients reported headaches within the first year after moderate or severe TBI. 46% of patients reported headaches at initial evaluation, and 44% reported new or persistent headaches at 1-year follow-up.<xref ref-type="bibr" rid="article-87083.r43">[43]</xref> A similar study reported that 91% of patients experienced headaches after mTBI. Furthermore, 54% reported headaches at initial evaluation, and 58% of patients reported headaches 1 year after injury.<xref ref-type="bibr" rid="article-87083.r44">[44]</xref></p>
      </sec>
      <sec id="article-87083.s11" sec-type="Complications">
        <title>Complications</title>
        <p>PTHA can be a considerable psychosocial deterrent for patients returning to their baseline activity before TBI. Up to 35% of PTHA patients do not return to work after 3 months.<xref ref-type="bibr" rid="article-87083.r2">[2]</xref> Also, due to the possible chronicity of PTHA, patients are at an increased risk of developing opioid dependence.<xref ref-type="bibr" rid="article-87083.r1">[1]</xref></p>
      </sec>
      <sec id="article-87083.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>No formal rehabilitation guidelines exist for PTHA. Physical therapy is indicated for cervicogenic headaches.</p>
      </sec>
      <sec id="article-87083.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients who have experienced traumatic brain injury should be educated on the potential for PTHA. While these headaches may be debilitating and possibly life-long, treatment options are available and include behavioral, pharmacological, and interventional. Furthermore, providers should reassure patients that&#x000a0;PTHA is not life-threatening. While there is no concrete clinical presentation for PTHA, patients and the care team should be aware that PTHA may take characteristics of primary and other secondary headaches.</p>
      </sec>
      <sec id="article-87083.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The clinician should attempt to identify the primary phenotype or nociceptive driver for the headache since not all PTHAs are the same. Future research in the treatment of PTHA should investigate the efficacy of cervical trigger point injections and sphenopalatine nerve blocks. These therapies are currently being investigated&#x000a0;for migraine headaches.<xref ref-type="bibr" rid="article-87083.r19">[19]</xref></p>
      </sec>
      <sec id="article-87083.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PTHA&#x000a0;requires an interprofessional team involving the patient, clinicians, pharmacists, and therapists. Providers must identify, evaluate, and manage PTHA as it can be debilitating and significantly affect the patient's quality of life after injury. While the IHS has attempted to classify PTHA based on chronology (acute versus persistent) and type of injury (mild vs. moderate/severe), there is a need to subdivide the various presentations of PTHA rather than simply by which characteristic primary headache fits the clinical presentation. Medical providers should seek to determine the primary headache phenotype and manage it accordingly. Additionally, patients with chronic PTHA should be assessed for medication-induced headaches that may arise due to the overuse of abortive headache therapy. The IHS acknowledges the lack of characteristic qualities in diagnosing PTHA, and more research is needed to assist providers in its overall management.<xref ref-type="bibr" rid="article-87083.r45">[45]</xref></p>
      </sec>
      <sec id="article-87083.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=87083&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=87083">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/migraine-headaches/posttraumatic-headache-headache-after-injury/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=87083">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/87083/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=87083">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-87083.s17">
        <title>References</title>
        <ref id="article-87083.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Onofrio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Conte</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Petretta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tedeschi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tessitore</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Post-traumatic headaches: a clinical overview.</article-title>
            <source>Neurol Sci</source>
            <year>2014</year>
            <month>May</month>
            <volume>35 Suppl 1</volume>
            <fpage>153</fpage>
            <page-range>153-6</page-range>
            <pub-id pub-id-type="pmid">24867854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashina</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Porreca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schytz</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Post-traumatic headache: epidemiology and pathophysiological insights.</article-title>
            <source>Nat Rev Neurol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>607</fpage>
            <page-range>607-617</page-range>
            <pub-id pub-id-type="pmid">31527806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theeler</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Headaches after concussion in US soldiers returning from Iraq or Afghanistan.</article-title>
            <source>Headache</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>1262</fpage>
            <page-range>1262-72</page-range>
            <pub-id pub-id-type="pmid">20553333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Onofrio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Conte</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Casucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tessitore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tedeschi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Post-traumatic headaches: an epidemiological overview.</article-title>
            <source>Neurol Sci</source>
            <year>2014</year>
            <month>May</month>
            <volume>35 Suppl 1</volume>
            <fpage>203</fpage>
            <page-range>203-6</page-range>
            <pub-id pub-id-type="pmid">24867867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sheedy</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A prospective controlled study in the prevalence of posttraumatic headache following mild traumatic brain injury.</article-title>
            <source>Pain Med</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>1001</fpage>
            <page-range>1001-11</page-range>
            <pub-id pub-id-type="pmid">18266807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwedt</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Peplinski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berisha</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Persistent post-traumatic headache vs. migraine: an MRI study demonstrating differences in brain structure.</article-title>
            <source>J Headache Pain</source>
            <year>2017</year>
            <month>Aug</month>
            <day>22</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <pub-id pub-id-type="pmid">28831776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Ay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lopes de Morais</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sadeghian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eikermann-Haerter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ayata</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Vagus nerve stimulation inhibits cortical spreading depression.</article-title>
            <source>Pain</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>157</volume>
            <issue>4</issue>
            <fpage>797</fpage>
            <page-range>797-805</page-range>
            <pub-id pub-id-type="pmid">26645547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cozzolino</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Marchese</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trovato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pracucci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ratto</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Buzzi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sicca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santorelli</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Understanding Spreading Depression from Headache to Sudden Unexpected Death.</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">29449828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartsch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater.</article-title>
            <source>Brain</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>Pt 8</issue>
            <fpage>1801</fpage>
            <page-range>1801-13</page-range>
            <pub-id pub-id-type="pmid">12821523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piovesan</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kowacs</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Oshinsky</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Convergence of cervical and trigeminal sensory afferents.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>377</fpage>
            <page-range>377-83</page-range>
            <pub-id pub-id-type="pmid">12946291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piantino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Newgard</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Iliff</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2019</year>
            <month>Jul</month>
            <day>29</day>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>62</fpage>
            <pub-id pub-id-type="pmid">31359173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>May</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hints on Diagnosing and Treating Headache.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2018</year>
            <month>Apr</month>
            <day>27</day>
            <volume>115</volume>
            <issue>17</issue>
            <fpage>299</fpage>
            <page-range>299-308</page-range>
            <pub-id pub-id-type="pmid">29789115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwedt</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Structural and Functional Brain Alterations in Post-traumatic Headache Attributed to Mild Traumatic Brain Injury: A Narrative Review.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>615</fpage>
            <pub-id pub-id-type="pmid">31258507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglas</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Wippold</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Aiken</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Amin-Hanjani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Germano</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Hadley</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jagadeesan</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Jurgens</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Mechtler</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Zipfel</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria Headache.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>657</fpage>
            <page-range>657-67</page-range>
            <pub-id pub-id-type="pmid">24933450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinlan</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Patient-Friendly Summary of the ACR Appropriateness Criteria Headache.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>3 Pt A</issue>
            <fpage>e5</fpage>
            <pub-id pub-id-type="pmid">29352715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Matsuzawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YSC</given-names>
              </name>
              <name>
                <surname>Minen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Behavioral Treatments for Post-Traumatic Headache.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2017</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>22</fpage>
            <pub-id pub-id-type="pmid">28283812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsen</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iljazi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Khazali</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Seem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schytz</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review.</article-title>
            <source>J Headache Pain</source>
            <year>2019</year>
            <month>Oct</month>
            <day>21</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <pub-id pub-id-type="pmid">31638888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lucchese</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Govindarajan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1009</fpage>
            <pub-id pub-id-type="pmid">31616362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conidi</surname>
                <given-names>FX</given-names>
              </name>
            </person-group>
            <article-title>Interventional Treatment for Post-traumatic Headache.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>40</fpage>
            <pub-id pub-id-type="pmid">27130542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoenen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials.</article-title>
            <source>Cephalalgia</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>165</fpage>
            <page-range>165-79</page-range>
            <pub-id pub-id-type="pmid">7553803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Packman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Packman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thurston</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Lumiracoxib is effective in the treatment of episodic tension-type headache.</article-title>
            <source>Headache</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>9</issue>
            <fpage>1163</fpage>
            <page-range>1163-70</page-range>
            <pub-id pub-id-type="pmid">16178946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bettucci</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Testa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Calzoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mantegazza</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monaco</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life.</article-title>
            <source>J Headache Pain</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-6</page-range>
            <pub-id pub-id-type="pmid">16514501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bendtsen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Buchgreitz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache.</article-title>
            <source>Eur J Neurol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>187</fpage>
            <page-range>187-93</page-range>
            <pub-id pub-id-type="pmid">17250728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbanti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Egeo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aurilia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fofi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Treatment of tension-type headache: from old myths to modern concepts.</article-title>
            <source>Neurol Sci</source>
            <year>2014</year>
            <month>May</month>
            <volume>35 Suppl 1</volume>
            <fpage>17</fpage>
            <page-range>17-21</page-range>
            <pub-id pub-id-type="pmid">24867829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burch</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Migraine and Tension-Type Headache: Diagnosis and Treatment.</article-title>
            <source>Med Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-233</page-range>
            <pub-id pub-id-type="pmid">30704678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forssell</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kalso</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koskela</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vehmanen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Puukka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alanen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials.</article-title>
            <source>Pain</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>83</volume>
            <issue>3</issue>
            <fpage>549</fpage>
            <page-range>549-560</page-range>
            <pub-id pub-id-type="pmid">10568864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pihut</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferendiuk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Szewczyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kasprzyk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wieckiewicz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.</article-title>
            <source>J Headache Pain</source>
            <year>2016</year>
            <volume>17</volume>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">27011213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Argoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>E</given-names>
              </name>
              <collab>Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society</collab>
            </person-group>
            <article-title>Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Apr</month>
            <day>24</day>
            <volume>78</volume>
            <issue>17</issue>
            <fpage>1346</fpage>
            <page-range>1346-53</page-range>
            <pub-id pub-id-type="pmid">22529203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pringsheim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Triptans for symptomatic treatment of migraine headache.</article-title>
            <source>BMJ</source>
            <year>2014</year>
            <month>Apr</month>
            <day>07</day>
            <volume>348</volume>
            <fpage>g2285</fpage>
            <pub-id pub-id-type="pmid">24711666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Acute Migraine Treatment.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4 Headache</issue>
            <fpage>953</fpage>
            <page-range>953-72</page-range>
            <pub-id pub-id-type="pmid">26252584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tepper</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Opioids should not be used in migraine.</article-title>
            <source>Headache</source>
            <year>2012</year>
            <month>May</month>
            <volume>52 Suppl 1</volume>
            <fpage>30</fpage>
            <page-range>30-4</page-range>
            <pub-id pub-id-type="pmid">22540203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Argoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>E</given-names>
              </name>
              <collab>Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society</collab>
            </person-group>
            <article-title>Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Apr</month>
            <day>24</day>
            <volume>78</volume>
            <issue>17</issue>
            <fpage>1337</fpage>
            <page-range>1337-45</page-range>
            <pub-id pub-id-type="pmid">22529202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hallett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Comella</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Gronseth</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Gloss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Potrebic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>So</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Yablon</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.</article-title>
            <source>Neurology</source>
            <year>2016</year>
            <month>May</month>
            <day>10</day>
            <volume>86</volume>
            <issue>19</issue>
            <fpage>1818</fpage>
            <page-range>1818-26</page-range>
            <pub-id pub-id-type="pmid">27164716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martelletti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van Suijlekom</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Cervicogenic headache: practical approaches to therapy.</article-title>
            <source>CNS Drugs</source>
            <year>2004</year>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>793</fpage>
            <page-range>793-805</page-range>
            <pub-id pub-id-type="pmid">15377169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Linde</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hagen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Salvesen</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Gravdahl</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Helde</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stovner</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study.</article-title>
            <source>Cephalalgia</source>
            <year>2011</year>
            <month>May</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>797</fpage>
            <page-range>797-807</page-range>
            <pub-id pub-id-type="pmid">21300635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bogduk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The neck and headaches.</article-title>
            <source>Neurol Clin</source>
            <year>2014</year>
            <month>May</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>471</fpage>
            <page-range>471-87</page-range>
            <pub-id pub-id-type="pmid">24703540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Traumatic neuroma of the superficial peroneal nerve in a patient: a case report and review of the literature.</article-title>
            <source>World J Surg Oncol</source>
            <year>2016</year>
            <month>Sep</month>
            <day>10</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>242</fpage>
            <pub-id pub-id-type="pmid">27613606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaibi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Manual therapies for cervicogenic headache: a systematic review.</article-title>
            <source>J Headache Pain</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>351</fpage>
            <page-range>351-9</page-range>
            <pub-id pub-id-type="pmid">22460941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Racicki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gerwin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diclaudio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reinmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review.</article-title>
            <source>J Man Manip Ther</source>
            <year>2013</year>
            <month>May</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-24</page-range>
            <pub-id pub-id-type="pmid">24421621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamer</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Purath</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Response of cervicogenic headaches and occipital neuralgia to radiofrequency ablation of the C2 dorsal root ganglion and/or third occipital nerve.</article-title>
            <source>Headache</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>500</fpage>
            <page-range>500-10</page-range>
            <pub-id pub-id-type="pmid">24433241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic Headache.</article-title>
            <source>Pain Res Manag</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>9617280</fpage>
            <pub-id pub-id-type="pmid">31065305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Starling</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Headache in Older Adults.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>252</fpage>
            <page-range>252-262</page-range>
            <pub-id pub-id-type="pmid">29406202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dikmen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Braden</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Brunner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Diaz-Arrastia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Natural history of headache after traumatic brain injury.</article-title>
            <source>J Neurotrauma</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>1719</fpage>
            <page-range>1719-25</page-range>
            <pub-id pub-id-type="pmid">21732765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Dikmen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of prevalence and characterization of headache following mild traumatic brain injury.</article-title>
            <source>Cephalalgia</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-102</page-range>
            <pub-id pub-id-type="pmid">23921798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-87083.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <article-title>Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</article-title>
            <source>Cephalalgia</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-211</page-range>
            <pub-id pub-id-type="pmid">29368949</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
